Results 221 to 230 of about 3,069,601 (247)

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. [PDF]

JCO Precis Oncol
Moussa MJ, Andreev-Drakhlin AY, Venkatesan AM, Matin SF, Xiao L, Tidwell RSS, Shah AY, Adriazola AC, Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT.   +17 more
europepmc   +1 more source

Antibody-drug conjugates in metastatic urothelial cancer: Highway to heaven. [PDF]

World J Clin Oncol
D'Angelo A, Catalano M, De Gennaro Aquino I, Gangi V, Roviello G.   +4 more
europepmc   +1 more source

Disitamab vedotin plus toripalimab as a first-line treatment for HER2-expressing advanced urothelial cancer: a cost-effectiveness analysis from China based on the RC48-C016 trial. [PDF]

Front Pharmacol
Yun X, Wu Q, Zeng C.
europepmc   +1 more source

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer. [PDF]

Nat Commun
Müller DC, Murtha AJ, Bacon JVW, Stephenson M, Wells C, Vasquez-Rios C, Rostin K, Rebane L, Schönlau E, Nikkola J, Alimohamed N, Basappa NS, Finch D, Ko JJ, Lavoie JM, Nappi L, Noonan K, Ong M, Ozgun G, Parimi S, Soleimani M, Sridhar SS, Toren P, Winquist E, Bernales CQ, Koudjanian M, Atwal J, Fung E, Khan L, Eigl B, Othman D, Bismar TA, Wang G, Merza R, Papadakis AI, Spatz A, Kollmannsberger C, Maurice-Dror C, Annala M, Chi KN, Vandekerkhove G, Wyatt AW, Eigl BJ.   +42 more
europepmc   +1 more source

Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-Oncology. [PDF]

Cancers (Basel)
Somoto T, Utsumi T, Ikeda R, Ishitsuka N, Noro T, Suzuki Y, Iijima S, Sugizaki Y, Oka R, Endo T, Kamiya N, Suzuki H.   +11 more
europepmc   +1 more source

The interplay of mutagenesis and extracellular DNA: a new chapter in urothelial cancer research. [PDF]

Mol Biomed
Zhang X, Li Y, Long X.
europepmc   +1 more source

First-line enfortumab vedotin-pembrolizumab versus nivolumab plus gemcitabine-cisplatin in metastatic urothelial cancer: a cost-effectiveness study. [PDF]

Front Public Health
Ying H, Fu B.
europepmc   +1 more source

Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomy. [PDF]

Sci Rep
Nicoletti R, Ho N, Lee HY, Wu WJ, Laukhtina E, Spatafora P, Wong CH, Ko IC, Leung CH, Giannarini G, Vasdev N, Gontero P, Ng CF, Li CC, Li WM, Ke HL, Yeh HC, Campi R, Serni S, Gacci M, Shariat S, Choi T, Teoh JY.   +22 more
europepmc   +1 more source